Fortimel
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Peking Union Medical College Hospital
Overview
Fortimel is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Fortimel clinical trials
Explore related
Medical disclaimer. This page summarizes research about Fortimel for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.